US Patent Issued to Mitsubishi Tanabe Pharma on May 27 for "Pharmaceutical composition for oral administration of edaravone and method of administering same" (Japanese Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,946, issued on May 27, was assigned to Mitsubishi Tanabe Pharma Corp. (Osaka, Japan).

"Pharmaceutical composition for oral administration of edaravone and method of administering same" was invented by Hidetoshi Shimizu (Osaka, Japan), Yoshinobu Nakamaru (Osaka, Japan) and Yukiko Nishimura (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating an oxidative stress disease includes orally or intragastrically administering, to a subject in need thereof, a pharmaceutical composition including edaravone with a time interval from a consumption of a meal by the subject in need thereof to an administration of the pharmaceutical com...